Brasília – The Constitution, Justice and Citizenship Committee (CCJ) of the House of Representatives approved the admissibility of Constitutional Amendment Proposal (PEC) No. 42/2024, which grants the lower chamber exclusive authority to oversee Brazil’s regulatory agencies. The measure, approved by 33 votes to 13, now proceeds to a special committee before being considered by the full House.

The proposal, sponsored by Representative Danilo Forte (União–CE), gathered 208 signatures—well above the minimum required. It stipulates that if parliamentary committees identify irregularities, omissions or misconduct within regulatory agencies, they must forward the findings to the Federal Public Prosecutor’s Office (MPF), the Office of the Attorney General (AGU) or the Federal Court of Accounts (TCU) for accountability actions.

Supporters argue that the amendment strengthens the legislative branch’s institutional oversight role, increasing transparency and balance among powers. Critics, however, warn that it could politicize agencies that depend on technical autonomy—such as Anvisa, ANS and ANEEL—potentially undermining regulatory stability in key sectors like health, energy and telecommunications.

Source: Broadcast

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com